Ads
related to: what is chemotherapy toxicity
Search results
Protein discovery could help prevent cancer treatment-related heart damage
Medical Xpress· 7 hours agoBased on an animal model, the study findings could provide a foundation for future treatment strategies to reduce chemotherapy-related heart toxicity and ...
Chemotherapy type can be personalized to decrease | Newswise
Newswise· 16 hours agoTaxane-based chemotherapies are the primary curative therapy for breast cancer, but they can lead to...
How to Cope With the Financial Toll of Cancer
Time via AOL· 5 hours agoHospital Chemotherapy Infusion Room Sign and Curtains. Credit - Getty Images Cancer isn’t just emotionally...the Journal of Clinical Oncology. This type...
CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab,...
Clearfield Progress· 2 days agoEMA CHMP recommendation is based on the results of a Phase 3 clinical trial (GEMSTONE-302) demonstrating significant progression-free survival (PFS) and overall survival (OS) benefits of sugemalimab ...
ASCO24: Akeso’s bispecific vvonescimab faces a rocky road ahead in NSCLC
Pharmaceutical Technology via Yahoo Finance· 2 days agoWith a low rate of Grade 3 or above VEGF-related adverse events observed in HARMONi, the dual...
RYBREVANT® (amivantamab-vmjw) plus lazertinib is the only chemotherapy-free regimen showing longer...
Morningstar· 3 days agoInvestigational chemotherapy-free regimen of RYBREVANT® plus lazertinib addresses a significant unmet need as most patients with EGFR-mutated NSCLC have high-risk disease ...
After Disappointing Bladder Cancer Data, Gilead Announces Encouraging Data From Gastric, Colorectal...
Benzinga· 4 hours agoGilead Sciences and Arcus Biosciences report sustained efficacy and safety in the Phase 2 EDGE-Gastric study for upper GI cancers, showing improved progression-free survival and objective response ...
Bristol’s $250,000 pill slows lung cancer growth by 7 weeks
San Francisco Chronicle· 6 hours agoThe treatment, called Krazati, was little better than standard chemotherapy in a study enrolling about 300 patients with advanced non-small cell lung cancer, according to ...
ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
Clinical Trials Arena via Yahoo Finance· 12 hours agoAbbVie has announced positive data for its antibody-drug conjugate (ADC) therapies, Teliso-V,...
Kinder, Gentler Regimen for Classical Hodgkin Prevails in Randomized Trial
MedPage Today· 3 days agoReplacing chemotherapy with a targeted agent resulted in a better tolerated regimen for advanced...
